4.7 Article

The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer

Journal

CANCER LETTERS
Volume 213, Issue 1, Pages 73-82

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2004.05.020

Keywords

vascular endothelial growth factor; microvessel density; survival; clinicopathological factor

Categories

Ask authors/readers for more resources

Placenta growth factor (PlGF) is a member of the vascular endothelial growth factor (VEGF) family of proangiogenic factors and its overexpression has been linked to pathological angiogenesis. We studied the relationship between the expression of PlGF and VEGF in human gastric cancer tissues and microvessel density (MVD), as well as clinical outcome in 79 patients with gastric cancer by using an enzyme immunoassay for PlGF and VEGF expression levels in gastric cancers and surrounding non-cancerous mucosa. PIGF protein levels were significantly higher in tumor than in the corresponding non-tumorous mucosa (median value 48.5 vs 9.8 pg/mg, P < 0.001). In contrast, VEGF protein levels were not (66.7 vs 80.7 pg/mg, P = 0.522). VEGF expression level was not significantly correlated with MVD, patient survival, and clinicopathological factors except Lauren classification in this study. PIGF may be an important angiogenic factor in human gastric cancer, and PIGF expression level was significantly correlated with serosal invasion, positive lymph node metastases, tumor stages, and patient survival. (C) 2004 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available